Connect
MJA
MJA

Pharmaceutical preparations

Ethics and law

Aligning legislation with clinical practice: off‐label prescribing under the microscope

Narcyz Ghinea

Med J Aust 2024; 221 (8): 417-419 Free

Research

Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021: a retrospective cohort study

Luke E Grzeskowiak, Vivienne Moore, Kelly Hall, Jenni Ilomäki, Danielle Schoenaker, Elizabeth Lovegrove, Danielle Mazza, Kirsten I Black, Debra S Kennedy, Michael J Davies and Alice Rumbold

Med J Aust 2024; 221 (7): 367-373 Free

Perspective

Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context

Narcyz Ghinea

Med J Aust 2024; 221 (8): 414-416 Free

Perspective

Pharmaceuticals in pregnancy: a multifaceted challenge in Australia

Stefan C Kane, Renuka Shanmugalingam and Amanda Henry

Med J Aust 2024; 221 (7): 357-359 Free

Perspective

Calling time on the use of modified‐release opioids for acute pain

Pamela E Macintyre, Melissa A Jamcotchian and Jennifer A Stevens

Med J Aust 2024; 221 (6): 293-296 Free

Medical education / Lessons from practice

Smouldering COVID‐19 XBB.1.5. subvariant pneumonitis: a case report

Sara Davison, Tanmay Kanitkar, Dimitrios Menouhos, Thomas Ewin, Catherine S Marshall, Peter Boan and Sonja Janson

Med J Aust 2024; 221 (5): 244-245 Free

Letter to the editor

Hidden danger: maize starch excipient allergy

Wala Hamid Haj Ali, Corey Borg and Catherine Leggett

Med J Aust 2024; 221 (5): 285-286 Free

Medical education / Key research skills

Understanding modelled economic evaluations: a reader's guide for clinicians

Winnie Chen, Martin Howell, Alan Cass, Gillian Gorham and Kirsten Howard

Med J Aust 2024; 221 (6): 302-307 Free

Editorial

The resurgence of congenital syphilis in Australia: novel approaches and sustained, effective public health efforts are required

Stephanie Bond and Marcus Y Chen

Med J Aust 2024; 221 (4): 195-196 Free

Editorial

Ensuring a fit‐for‐purpose resource for consumers, clinicians and health services: the updated Osteoarthritis of the Knee Clinical Care Standard

Ilana N Ackerman, Fiona Doukas, Rachelle Buchbinder, Sally Dooley, Wendy Favorito, Phoebe Holdenson Kimura, David J Hunter, James Linklater, John B North, Louise Elvin‐Walsh, Christopher Vertullo, Alice L Bhasale and Samantha Bunzli

Med J Aust 2024; 221 (4): 197-200 Free

Medical education / Lessons from practice

Treatment‐resistant tinea caused by Trichophyton indotineae in Australia

Kyra YL Chua, Catriona L Halliday, Sharon C‐A Chen, Sonia Koning, Jedrzej Pawlikowski, Philipp du Cros and Tony M Korman

Med J Aust 2024; 221 (4): 192-194 Free

Perspective

National pharmacovigilance of seasonal influenza vaccines in Australia

Megan O'Moore, Belinda Jones, Megan Hickie, Catherine Glover, Lucy Deng, Yuanfei Huang, Michael Dymock, Evelyn Tay, Julie A Marsh and Nicholas Wood

Med J Aust 2024; 221 (4): 178-181 Free

Letters

Is the current commercial model of medicinal cannabis in the best interest of patients?

Richard CJ Bradlow and Ferghal Armstrong

Med J Aust 2024; 220 (11): 592-592 Free

Perspectives

Ethics of artificial intelligence in supportive care in cancer

Ian N Olver

Med J Aust 2024; 220 (10): 499-501 Free

Medical education / Lessons from practice

Measurement of digoxin levels falsely affected by enzalutamide

Noor Lammoza, Maria Hormiz, Cherie Chiang, Chris Stead, Mustafa Ayhan and Samuel C Hume

Med J Aust 2024; 220 (9): 455-456 Free

Research letter

Pharmaceutical company payments to Australian doctors reported to Medicines Australia, 2019–22: a cross‐sectional analysis

Malcolm Forbes, Yeshna Bhowon and Barbara Mintzes

Med J Aust 2024; 220 (8): 425-427 Free

Editorials

Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?

Suzanne Nielsen and Ting Xia

Med J Aust 2024; 220 (6): 311-312

Research

The impact of tightened prescribing restrictions for PBS-subsidised opioid medicines and the introduction of half-pack sizes, Australia, 2020–21: an interrupted time series analysis

Forrest C Koch, Jake Olivier, Jonathan Brett, Nicholas A Buckley, Natasa Gisev, Sallie Pearson and Benjamin Daniels

Med J Aust 2024; 220 (6): 315-322 Free

Research letters

The uptake of long‐acting depot buprenorphine for treating opioid dependence in Australia, 2019–2022: longitudinal sales data analysis

Nicholas Lintzeris, Victoria Hayes and Adrian J Dunlop

Med J Aust 2024; 220 (6): 339-340 Free

Editorial

Antibiotics or watchful waiting for acute otitis media in urban Aboriginal and Torres Strait Islander children?

Valerie M Swift and Christopher G Brennan‐Jones

Med J Aust 2024; 220 (4): 186-187 Free

Medical education / Lessons from practice

Hidden danger: maize starch excipient allergy

Lipin Lukose, Shrey Seth, Kamal Sud, Brian Nankivell, Mary Ann Nicdao and Ronald L Castelino

Med J Aust 2024; 220 (4): 184-185 Free

Research

The views of parents and carers on managing acute otitis media in urban Aboriginal and Torres Strait Islander children: a qualitative study

Jennifer S Reath, Sarah O'Brien, Letitia Campbell, Hasantha Gunasekera, Claudette A Tyson, Deborah A Askew, Wendy Hu, Tim Usherwood, Kelvin Kong, Peter Morris, Amanda J Leach, Robyn Walsh and Penelope A Abbott

Med J Aust 2024; 220 (4): 202-207 Free

Perspectives

Inflammation: the next target for secondary prevention in coronary artery disease

Samia Kazi, James J H Chong and Clara K Chow

Med J Aust 2024; 220 (3): 115-120 Free

Letters

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Thomas Cueni and Elizabeth Somer

Med J Aust 2023; 219 (9): 439-439 Free

Letters

Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Deborah Gleeson, James Scheibner and Dianne Nicol

Med J Aust 2023; 219 (9): 439-439 Free